CClinicalTrials.gg
CompletedNCT03303820Updated Oct 6, 2017

Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients

An observational study in Thrombosis, sponsored by Fondation Hôpital Saint-Joseph. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-10-06.

Sponsored by Fondation Hôpital Saint-Joseph · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
73
Ages
18 Years and older
Sex
All
01

Study summary

Many clinical trials show that 30 to 50 % of the hospitalized patients are undernourished in various degrees. This prevalence didn't change since 15-20 years The fact is that the present undernutrition in the admission deteriorates during the hospitalization.

Besides, the cerebral vascular accident (AVC) complicates the first days, in at least 50 % of the cases, the disorders of the gulp, which are a risk factor of acquired undernutrition. The nutrition holds an important place in the therapeutic coverage of the AVC. Nevertheless, the link between the undernutrition the entrance and the evolution of the AVC is at the moment only little known. The purpose is to study the impact of the undernutrition in the entrance to the hospital (undernutrition previous to the AVC), on the gravity and the evolution

02

Conditions studied

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

patient admitted in hospital for vascular cerebral accident in 2015 with thrombolytic treatment

Inclusion criteria

  • patient admitted in hospital for vascular cerebral accident in 2015
  • thrombolytic treatment

Exclusion criteria

Exclusion Criteria:

  • no thrombolytic treatment
  • transcient ischaemic attack
04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
73 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Rankin score

    measurement of Rankin score at the entrance and at the end of hospitalisation

    Time frame: Day 1; last day of hospitalisation

06

Study locations

1 site
  • Groupe Hospitalier Paris Saint Joseph
    Paris, Ile-de-France 75014, France
07

Registry details

Key details

Study ID
NCT03303820
Lead sponsor
Fondation Hôpital Saint-Joseph
Responsible party
Sponsor
First posted
Oct 6, 2017
Start date
May 27, 2016
Primary completion
May 27, 2017
Completion
Aug 31, 2017
Last update
Oct 6, 2017

Study contacts

ZUBER Mathieu, Professor
study director · GHPSJ

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion